Reopening Of Public Comment Period For Opioid Class REMS Confirms Long Road Ahead
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is reopening the public comment period for the class-wide opioid Risk Evaluation and Mitigation Strategy until Oct. 19, 2010.